Year: 2023

Takeda_Red_Logo_2021

Takeda Announces Positive Results in Phase 2b Study of Investigational TAK-279, an Oral, Once-Daily TYK2 Inhibitor, in People with Moderate-to-Severe Plaque Psoriasis

Results for TAK-279 (Formerly NDI-034858) Show a Significantly Greater Proportion of Patients Achieved Psoriasis Area and Severity Index (PASI) 75...

1._WEA_Master_Logo_RED_3.25.21

The Women’s Entrepreneurship Accelerator Celebrates Three-Year Anniversary Milestone at Geneva Event with the Launch of the Digital Innovation Challenge for Women Start-ups in Partnership with International Telecommunication Union

NEW YORK & GENEVA--(BUSINESS WIRE)--Recognizing the intersecting relationship between innovation, technology, the digital space and gender inequality, the Women’s Entrepreneurship...